The pharmacogenetics of codeine pain relief in the postpartum period (original) (raw)
CYP2D6 Polymorphisms and Codeine Analgesia in Postpartum Pain Management: A Pilot Study
violette gijsen
Therapeutic Drug Monitoring, 2011
View PDFchevron_right
Cross-sectional analysis of the influence of currently known pharmacogenetic modulators on opioid therapy in outpatient pain centers
Rainer Freynhagen
Pharmacogenetics and Genomics, 2009
View PDFchevron_right
Pharmacogenomics of Pain Management: The Impact of Specific Biological Polymorphisms on Drugs and Metabolism
Jasmine Rivas
Current Oncology Reports, 2020
View PDFchevron_right
Pharmacogenetics of Neonatal Opioid Toxicity Following Maternal Use of Codeine During Breastfeeding: A Case-Control Study
A. Gaedigk
Clinical Pharmacology & Therapeutics, 2009
View PDFchevron_right
Same incidence of adverse drug events after codeine administration irrespective of the genetically determined differences in morphine formation
Klaus Eckhardt
Pain, 1998
View PDFchevron_right
Pharmacogenetics and postoperative pain: a new approach to improve acute pain management
C. Minella, Massimo Allegri, Stefano Govoni
Minerva anestesiologica, 2010
View PDFchevron_right
CYP2D6 Pharmacogenetics Testing and Post-Cesarean Section Pain Scores-a Preliminary Study
Ana Valentim
Pain medicine (Malden, Mass.), 2018
View PDFchevron_right
Pain polymorphisms and opioids: An evidence based review
ROSA FRAGOSO
Molecular Medicine Reports, 2018
View PDFchevron_right
The Impact of Genetics and Other Factors on Intra- and Post-partum Pain
pascal vuilleumier
Current Anesthesiology Reports, 2013
View PDFchevron_right
A review of the role of genetic testing in pain medicine
Andrea Trescot
Pain physician
View PDFchevron_right
Pharmacogenetics of Pain
Maree T Smith
eLS, 2001
View PDFchevron_right
Authors' Response to Peer Reviews of “Effects of Pharmacogenomic Testing in Clinical Pain Management: Retrospective Study”
Mary Jane Marines
JMIRx med, 2022
View PDFchevron_right
{"__content__"=>" genotype can help to predict effectiveness and safety during opioid treatment for chronic low back pain: results from a retrospective study in an Italian cohort.", "i"=>{"__content__"=>"CYP2D6"}}
Concetta Dagostino
Pharmacogenomics and personalized medicine, 2018
View PDFchevron_right
Pharmacogenetics of pain and analgesia
Maree T Smith
Clinical Genetics, 2012
View PDFchevron_right
Genetic Predictors of the Clinical Response to Opioid Analgesics
Carsten Skarke
Clinical Pharmacokinetics, 2004
View PDFchevron_right
Authors' Response to Peer Reviews of “Effects of Pharmacogenomic Testing in Clinical Pain Management: Retrospective Study” (Preprint)
Mary Jane Marines
2022
View PDFchevron_right
The Role of Genetic Polymorphisms in Chronic Pain Patients
Kenneth Candido
International journal of molecular sciences, 2018
View PDFchevron_right
Pharmacogenomics of Analgesic Agents
Amy Drendel
Clinical Pediatric Emergency Medicine, 2007
View PDFchevron_right
<em>CYP2D6</em> genotype can help to predict effectiveness and safety during opioid treatment for chronic low back pain: results from a retrospective study in an Italian cohort
Valerio Napolioni
Pharmacogenomics and Personalized Medicine, 2018
View PDFchevron_right
PROGRESS IN GENETIC PAIN STUDIES REGARDING ANALGESICS THERAPY-A Systemic Review PART I-GENETIC MODULATION OF PAIN from genotype-phenotype
Veronica Bild
2018
View PDFchevron_right
Pharmacogenetic guidance: individualized medicine promotes enhanced pain outcomes
Jeffrey Fudin
Journal of pain research, 2018
View PDFchevron_right
Genetic Testing for Opioid Pain Management: A Primer
Andrea Trescot
Pain and Therapy, 2017
View PDFchevron_right
Fundamental Considerations for GeneticallyGuided Pain Management with Opioids Based on CYP2D6 and OPRM1 Polymorphisms
jonathan kost
January 2018
View PDFchevron_right
Pharmacogenomics of pain drugs used in palliative care
Dr. Mohitosh Biswas
Aus Pharmacist, 2017
View PDFchevron_right
Pharmacogenetics and chronic pain management.
Prateek Lala
Clinical Biochemistry, 2014
View PDFchevron_right
Genetic Variability of Pharmacokinetics and Pharmacodynamics of Analgesics (Layered Medicine)
Veronica Bild
2019
View PDFchevron_right
Pharmacogenetics of opioids: a narrative review
Pankaj Kundra
Anaesthesia
View PDFchevron_right
Different SNP combinations in the GCH1 gene and use of labor analgesia
Helena Akerud, Inger Poromaa
Molecular Pain, 2010
View PDFchevron_right
Pharmacogenetic study of pruritus induced by epidural morphine for post cesarean section analgesia
Li-kuei Chen
Taiwanese Journal of Obstetrics and Gynecology, 2018
View PDFchevron_right
The pharmacogenomics of pain management: prospects for personalized medicine
Stephan Schug
Journal of pain research, 2016
View PDFchevron_right
Genetics and genomics in postoperative pain and analgesia
Mari Kaunisto
Current Opinion in Anaesthesiology, 2018
View PDFchevron_right
Pharmacogenetics of chronic pain management
Prateek Lala
Clinical Biochemistry, 2014
View PDFchevron_right
Pharmacogenomics in pain treatment
Jérôme Busserolles
Drug metabolism and personalized therapy, 2016
View PDFchevron_right
Influence from genetic variability on opioid use for cancer pain: A European genetic association study of 2294 cancer pain patients
R. Sabatowski
PAIN, 2011
View PDFchevron_right
A Genetic Association Study of the Functional A118G Polymorphism of the Human ??-Opioid Receptor Gene in Patients with Acute and Chronic Pain
Berend Mets
Anesthesia & Analgesia, 2006
View PDFchevron_right